Matthew N. Sirott

Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysis

D. Bajorin, A. Houghton, P. Chapman, 1993, Cancer.

A phase II trial of interferon alpha‐2A, 5‐fluorouracil, and cisplatin in patients with advanced esophageal carcinoma

Ying Huang, R. Heelan, D. Kelsen, 1995, Cancer.

Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor.

L. Saltz, D. Niedzwiecki, K. Barbosa, 1993, Journal of the National Cancer Institute.